Cubist Systematic Strategies, LLC Shattuck Labs, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.37 - $7.24 $48,559 - $256,621	35,445 New	35,445 $252,000
Q4 2022 Feb 14, 2023	SELL	$1.96 - $3.26 $9,805 - $16,309	-5,003 Reduced 29.49%	11,960 $27,000
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.52 $21,283 - $45,186	-8,186 Reduced 32.55%	16,963 $46,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $4.59 $391 - $665	145 Added 0.58%	25,149 $102,000
Q1 2022 May 16, 2022	SELL	$4.22 - $8.89 $62,502 - $131,669	-14,811 Reduced 37.2%	25,004 $107,000
Q4 2021 Feb 14, 2022	BUY	$8.36 - $21.08 $332,853 - $839,300	39,815 New	39,815 $339,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $50.4M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.